Vulvovaginal Atrophy Clinical Trial
Official title:
Prospective, Open-label, Monocenter, Trial to Investigate the Efficacy and Tolerability of WO533, a Lactic Acid Containing Vaginal Suppository, in a Panel of Post-menopausal Women Suffering From Vulvovaginal Atrophy (VVA)
The aim of the study is to investigate the efficacy and tolerability of a lactic acid containing vaginal suppository with respect to the application in post-menopausal women with VVA.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04210583 -
RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
|
N/A | |
Completed |
NCT03725410 -
Multi-polar RF and PEMF for Treatment of Symptoms Associated With Vulvovaginal Atrophy
|
N/A | |
Recruiting |
NCT03823560 -
Performance and Safety of Class IIb MD Celegyn® in VVA
|
N/A | |
Completed |
NCT02253173 -
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
Withdrawn |
NCT03666819 -
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
|
Phase 2 | |
Recruiting |
NCT04746456 -
Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
|
||
Completed |
NCT04607798 -
Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy
|
N/A | |
Completed |
NCT04766957 -
Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy
|
N/A | |
Completed |
NCT01455597 -
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
|
Phase 3 | |
Completed |
NCT03557398 -
Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women
|
N/A | |
Completed |
NCT03044652 -
Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol
|
Phase 4 | |
Completed |
NCT03536585 -
Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
|
N/A | |
Completed |
NCT04629885 -
Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms
|
Phase 2 | |
Recruiting |
NCT04579991 -
Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women
|
N/A | |
Recruiting |
NCT05562518 -
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
|
Phase 4 | |
Completed |
NCT02419729 -
Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy
|
Phase 3 | |
Completed |
NCT02085980 -
Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy
|
N/A | |
Completed |
NCT01319968 -
Postpartum Dyspareunia Resulting From Vaginal Atrophy
|
N/A | |
Recruiting |
NCT03782480 -
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
|
Phase 3 | |
Completed |
NCT04887701 -
Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women
|
N/A |